Coexistence of narcolepsy and Alzheimer's disease - PubMed (original) (raw)

Review

Coexistence of narcolepsy and Alzheimer's disease

T E Scammell et al. Neurobiol Aging. 2012 Jul.

Abstract

A recent publication suggested that hypocretin (Hcrt, orexin) may mediate the neuropathological process leading to Alzheimer's disease (AD) and that antagonism of hypocretin receptors decreases this process. Narcoleptics have an approximately 90% loss of Hcrt neurons and commensurate reductions in the levels of Hcrt in their cerebrospinal fluid beginning at disease onset, usually before the age of 30. If Hcrt mediates the disease process, narcoleptics should be protected against AD. We examined the postmortem neuropathology and clinical records of 12 sequentially encountered cases of human narcolepsy. We found that AD was present in 4 of these narcoleptics, a prevalence that is similar to that of the general population.

Published by Elsevier Inc.

PubMed Disclaimer

Similar articles

• Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.
  John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M, Siegel JM. John J, et al. Ann Neurol. 2013 Dec;74(6):786-93. doi: 10.1002/ana.23968. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23821583 Free PMC article.
• Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
  Thannickal TC, Nienhuis R, Siegel JM. Thannickal TC, et al. Sleep. 2009 Aug;32(8):993-8. doi: 10.1093/sleep/32.8.993. Sleep. 2009. PMID: 19725250 Free PMC article.
• Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
  Kasanuki K, Iseki E, Kondo D, Fujishiro H, Minegishi M, Sato K, Katsuse O, Hino H, Kosaka K, Arai H. Kasanuki K, et al. Neurosci Lett. 2014 May 21;569:68-73. doi: 10.1016/j.neulet.2014.03.020. Epub 2014 Apr 2. Neurosci Lett. 2014. PMID: 24704327
• Sleep, sleep disorders and hypocretin (orexin).
  Mignot E. Mignot E. Sleep Med. 2004 Jun;5 Suppl 1:S2-8. doi: 10.1016/s1389-9457(04)90001-9. Sleep Med. 2004. PMID: 15301991 Review.
• [Narcolepsy with cataplexy].
  Dauvilliers Y, Arnulf I. Dauvilliers Y, et al. Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):634-45. doi: 10.1016/j.neurol.2007.08.012. Epub 2008 Mar 4. Rev Neurol (Paris). 2008. PMID: 18805301 Review. French.

Cited by

• Effects of an OX2R agonist on migration and removal of tau from mouse brain.
  Terada M, Mitsukawa K, Nakakariya M, Koike T, Kimura H. Terada M, et al. Sci Rep. 2024 Jul 10;14(1):15964. doi: 10.1038/s41598-024-64817-8. Sci Rep. 2024. PMID: 38987562 Free PMC article.
• Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation.
  Ahmadian N, Hejazi S, Mahmoudi J, Talebi M. Ahmadian N, et al. Basic Clin Neurosci. 2018 Sep-Oct;9(5):307-316. doi: 10.32598/bcn.9.5.307. Epub 2018 Sep 1. Basic Clin Neurosci. 2018. PMID: 30719245 Free PMC article. Review.
• Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
  Moghekar A, O'Brien RJ. Moghekar A, et al. Alzheimers Res Ther. 2012 Aug 13;4(4):26. doi: 10.1186/alzrt129. eCollection 2012. Alzheimers Res Ther. 2012. PMID: 22883923 Free PMC article.
• Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy.
  Seifinejad A, Ramosaj M, Shan L, Li S, Possovre ML, Pfister C, Fronczek R, Garrett-Sinha LA, Frieser D, Honda M, Arribat Y, Grepper D, Amati F, Picot M, Agnoletto A, Iseli C, Chartrel N, Liblau R, Lammers GJ, Vassalli A, Tafti M. Seifinejad A, et al. Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2220911120. doi: 10.1073/pnas.2220911120. Epub 2023 May 1. Proc Natl Acad Sci U S A. 2023. PMID: 37126681 Free PMC article.
• Ictal SPECT in patients with rapid eye movement sleep behaviour disorder.
  Mayer G, Bitterlich M, Kuwert T, Ritt P, Stefan H. Mayer G, et al. Brain. 2015 May;138(Pt 5):1263-70. doi: 10.1093/brain/awv042. Epub 2015 Mar 1. Brain. 2015. PMID: 25732183 Free PMC article.

References

1. 1. Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM, 2005. Narp immunostaining of human hypocretin (orexin) neurons: Loss in narcolepsy. Neurology 65, 1189–1192. - PMC - PubMed
2. 1. Crocker A, Espana RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE, 2005. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65, 1184–1188. - PMC - PubMed
3. 1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO, 1989. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 262, 2551–2556. - PubMed
4. 1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA, 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119–1122. - PubMed
5. 1. Honda M, Arai T, Fukazawa M, Honda Y, Tsuchiya K, Salehi A, Akiyama H, Mignot E, 2009. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology 73, 511–517. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

• R01 NS014610/NS/NINDS NIH HHS/United States
• R01 DA034748/DA/NIDA NIH HHS/United States
• NS14610/NS/NINDS NIH HHS/United States
• R01 MH064109/MH/NIMH NIH HHS/United States
• R37 NS014610/NS/NINDS NIH HHS/United States
• I01 BX001753/BX/BLRD VA/United States
• MH64109/MH/NIMH NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information